Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Public ClinicalTrials.gov record NCT07194044. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT07194044
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Other
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Interventions
- Actinomycin Drug
- Cabozantinib Drug
- Cyclophosphamide Drug
- Doxorubicin Drug
- Etoposide Drug
- Ifosfamide Drug
- Irinotecan Drug
- Liposomal doxorubicin Drug
- Temozolomide Drug
- Topotecan Drug
- Vincristine Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Year and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2026
- Primary completion
- Sep 30, 2030
- Completion
- Sep 30, 2030
- Last update posted
- Mar 15, 2026
2026 – 2030
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham (Children's of Alabama) | Birmingham | Alabama | 35233 | Recruiting |
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | Not yet recruiting |
| Connecticut Children's Medical Center | Hartford | Connecticut | 06106 | Not yet recruiting |
| University of Florida | Gainesville | Florida | 32610 | Recruiting |
| Nemours Jacksonville | Jacksonville | Florida | 32207 | Not yet recruiting |
| University of Miami | Miami | Florida | 33136 | Recruiting |
| Moffitt Cancer Center | Tampa | Florida | 33612 | Recruiting |
| University of Kentucky | Lexington | Kentucky | 40536 | Not yet recruiting |
| Helen DeVos Children's Hospital | Grand Rapids | Michigan | 49503 | Not yet recruiting |
| Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14263 | Not yet recruiting |
| Montefiore Medical Center | The Bronx | New York | 10467 | Not yet recruiting |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | Not yet recruiting |
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | Not yet recruiting |
| Cleveland Clinic Children's | Cleveland | Ohio | 44195 | Not yet recruiting |
| Nationwide Children's Hospital | Columbus | Ohio | 43205 | Recruiting |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Not yet recruiting |
| Primary Children's Hospital | Salt Lake City | Utah | 84113 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07194044, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 15, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07194044 live on ClinicalTrials.gov.